Showing results (1621-1630 of 1,838) with videos related to

Sort By:
Pageof 184
The American Journal of Cardiology|January 28, 2010
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF)Clyde W Yancy, Gregg C Fonarow, Nancy M Albert, et al.
BMC Medical Genetics|November 23, 2017
Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarctionReza Jabbari, Javad Jabbari, Charlotte Glinge, et al.
American Heart Journal|December 5, 2009
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HFAnne B Curtis, Clyde W Yancy, Nancy M Albert, et al.
Heart Rhythm|December 5, 2009
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HFMandeep R Mehra, Clyde W Yancy, Nancy M Albert, et al.
Environmental Health Perspectives|May 6, 2021
Effects of Low-Dose Gestational TCDD Exposure on Behavior and on Hippocampal Neuron Morphology and Gene Expression in MiceTalia E Gileadi, Abhyuday K Swamy, Zoe Hore, et al.
Lancet Regional Health. Americas|April 6, 2026
Remote digital intervention targeting heart failure medical therapy: a randomized controlled trialAdam D DeVore, Cynthia L Green, Nancy M Albert, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
Breast Cancer Research and Treatment|May 10, 2011
Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional controlJeffrey M Albert, Aman U Buzdar, Reina Guzman, et al.
The American Journal of Cardiology|January 8, 2011
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial)Christopher M O'Connor, Nancy M Albert, Anne B Curtis, et al.
Congestive Heart Failure (Greenwich, Conn.)|January 27, 2012
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HFMihai Gheorghiade, Nancy M Albert, Anne B Curtis, et al.
Pageof 184